➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Mallinckrodt
Boehringer Ingelheim
Harvard Business School
McKinsey

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

Patent Applications for METHADONE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US Patent Applications for METHADONE HYDROCHLORIDE

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
  Start Trial   Start Trial TELE-DIAGNOSTIC DEVICE 2000-12-19 Patented Case 2003-03-12
  Start Trial   Start Trial FATTY ACID-PHARMACEUTICAL AGENT CONJUGATES 2000-12-05 Patented Case 2003-05-21
  Start Trial   Start Trial Sustained release compositions and a method of preparing pharmaceutical compositions 2000-12-19 Abandoned -- Failure to Respond to an Office Action 2002-12-30
  Start Trial   Start Trial Use of sulfamate derivatives for treating impulse control disorders 2000-02-18 Patented Case 2001-11-09
  Start Trial   Start Trial METHODS FOR TREATING OVARIAN CANCER, POLY (PHOSPHOESTER) COMPOSITIONS, AND BIODEGRADABLE ARTICLES FOR SAME 2001-03-28 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2014-12-08
  Start Trial   Start Trial POLYMORPHIC FORM OF A TACHYKININ RECEPTOR ANTAGONIST 2001-05-07 Patented Case 2002-07-25
  Start Trial   Start Trial PHARMACOKINETIC-BASED DRUG DESIGN TOOL AND METHOD 1999-05-26 Abandoned -- Failure to Respond to an Office Action 2002-10-01
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

WIPO Patent Applications for METHADONE HYDROCHLORIDE

WIPO Patent Application Title Patent Filing Date
  Start Trial
>WIPO Patent Application >Title >Patent Filing Date

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
AstraZeneca
Boehringer Ingelheim
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.